Artificial intelligence is already proving to be a valuable tool in the field of neuroscience. It aids in our understanding of how the human brain functions as well as the advancement of neuroscience. In the history of artificial intelligence, neuroscience has played a significant role. It has been used as a model for creating AI that is human-like. Neuroscience can inspire us to create AI systems in two ways. One is to develop neural networks that replicate brain structure, and the other is to emulate human intelligence. The emergence of more powerful processors and ever-increasing amounts of training data has contributed significantly to AI's success. Artificial intelligence advancements can aid in the advancement of neuroscience and the unlocking of the brain's secrets. It enables neuroscientists and researchers to create more accurate models of the human brain.
Title : Perception and individuality
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : The foundation and architecture of Personalized & Precision Medicine (PPM) in clinical neurology: Towards curative and neurodegenerative disease-modifying treatment for multiple sclerosis
Sergey Suchkov, The Russian University of Medicine and The Russian Academy of Natural Sciences, Russian Federation
Title : Narrative medicine: A communication therapy for the communication disorder of Psychogenic Non-Epileptic Seizures (PNES) also known as Functional Seizures (FS)
Robert B Slocum, University of Kentucky HealthCare, United States
Title : GABA-A receptor modulating steroid antagonists decrease GABAergic tone, improve memory impairment, attenuates fatigue, and decrease neuroinflammation
Torbjorn Backstrom, Umea Neurosteroid Research Center, Sweden
Title : Neuroimaging by evaluation nerverenovate and neuroplasticity of acupuncture in children with cerebral palsy
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Antibody-Ppoteases as the upgraded translational tools of the next-step generation in personalized and precision practice to monitor multiple sclerosis at clinical and subclinical Stages
Sergey Suchkov, The Russian University of Medicine and The Russian Academy of Natural Sciences, Russian Federation